Using Vedolizumab to Treat Severe Sweet's Syndrome in a Patient With Ulcerative Colitis.

Belvis Jiménez, MMaldonado Pérez, BArgüelles-Arias, F2023-01-252023-01-252018http://hdl.handle.net/10668/12498enAntibodies, Monoclonal, HumanizedColitis, UlcerativeGastrointestinal AgentsHumansMaleSweet SyndromeYoung AdultUsing Vedolizumab to Treat Severe Sweet's Syndrome in a Patient With Ulcerative Colitis.research article29788419open access10.1093/ecco-jcc/jjy0661876-4479https://academic.oup.com/ecco-jcc/article-pdf/12/9/1134/25571561/jjy066.pdf